Form 4: Marvell Technology CEO Matthew Murphy Sells 30,000 Shares
SEC Form 4 Filing
Marvell Technology's CEO, Matthew Murphy, sold 30,000 shares of common stock at an average price of $66.17 on March 14, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 14, 2024, Matthew J. Murphy, the Chair of the Board, President, and CEO of Marvell Technology, Inc., sold 30,000 shares of the company's common stock.
- The sale was executed at a weighted average price of $66.17 per share.
- The transactions occurred under a pre-arranged 10b5-1 trading plan established on September 15, 2022, and modified on March 21, 2023.
- Following the transaction, Murphy directly owns no shares and indirectly owns 732,929 shares through a family trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an executive stock sale. It doesn't inherently convey positive or negative sentiment, as it's a factual report of a transaction executed under a pre-existing plan.
Industry Context
Executive stock sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information. Investors often monitor these transactions for insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive stock sales are a common practice across the technology industry.
- Companies like NVIDIA, AMD, and Qualcomm also see regular insider trading activity.
- The use of 10b5-1 plans is a standard method for executives to manage their stock holdings while avoiding potential insider trading accusations.
Stakeholder Impact
- The stock sale could have a minor impact on shareholder sentiment, depending on how the market interprets the transaction.
- However, given the use of a 10b5-1 plan, the impact is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 07/10/2007 | Date of the Matthew and Laura Murphy Family Trust UTD |
| 09/15/2022 | Date of the 10b5-1 Plan |
| 03/21/2023 | Date the 10b5-1 Plan was modified |
| 03/14/2024 | Date of the stock sale transaction |
| 03/18/2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.